|
Having trouble viewing this email? View it as a Web page.
The next session of Public Health Grand Rounds, entitled “The Growing Threat of Multidrug-Resistant Gonorrhea,” will be held on Tuesday, May 15 at 1 p.m. (EDT). This session of Grand Rounds will explore the development of antibiotic resistance in Neisseria gonorrhoeae as a growing public health concern because the United States gonorrhea control strategy relies on effective antibiotic therapy. Since antibiotics were first used for treatment of gonorrhea, the organism has progressively developed resistance to the drugs prescribed to treat it. Given the ability of the gonorrhea bacterium to develop antibiotic resistance, it is critical to continuously monitor gonococcal antibiotic resistance and encourage research and development of new treatment regimens for gonorrhea. CDC’s Public Health Grand Rounds Presents: Presented By: Edward Hook III, MD William Shafer, PhD Carolyn Deal, PhD Robert D. Kirkcaldy, MD, MPH Facilitated By: Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds For information about how to view, register, or receive continuing education for this free event, please visit: http://www.cdc.gov/about/grand-rounds/index.htm.
You received this email because you are subscribed to the STD Treatment web page on the Centers for Disease Control and Prevention (CDC) web site. If you want to change your subscription preferences, please use the links below.
Modify/Update Subscriber Preferences | Unsubscribe | Send Feedback | Learn more about CDC Email Updates To receive the latest news for your region, please update your profile with your country, state and zip code. Questions or problems? Please contact support@xxxxxxxxxxxxxxx.
|
|||||||||||||||||||||||||||||||||||
